A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness
Public ClinicalTrials.gov record NCT00435227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate a Single Intramuscular Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Outpatient Treatment of Children With RSV Illness
Study identification
- NCT ID
- NCT00435227
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MedImmune LLC
- Industry
- Enrollment
- 12 participants
Conditions and interventions
Interventions
- Motavizumab Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 0 Months to 12 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 19, 2007
- Primary completion
- May 30, 2008
- Completion
- May 30, 2008
- Last update posted
- Aug 16, 2021
2007 – 2008
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tucson | Arizona | — | — |
| Research Site | Jonesboro | Arkansas | 72401 | — |
| Research Site | Jonesboro | Arkansas | — | — |
| Research Site | Little Rock | Arkansas | 72202 | — |
| Research Site | Little Rock | Arkansas | — | — |
| Research Site | Orange | California | 92868 | — |
| Research Site | San Diego | California | 92103 | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Tampa | Florida | 33606 | — |
| Research Site | Atlanta | Georgia | 30342 | — |
| Research Site | Augusta | Georgia | 30912 | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Boston | Massachusetts | 02111 | — |
| Research Site | Detroit | Michigan | 48201 | — |
| Research Site | Las Vegas | Nevada | 89107 | — |
| Research Site | Paterson | New Jersey | 07503 | — |
| Research Site | Brooklyn | New York | 11203-2098 | — |
| Research Site | Buffalo | New York | 14222-2099 | — |
| Research Site | The Bronx | New York | — | — |
| Research Site | Youngstown | Ohio | 44051 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Nashville | Tennessee | 37232-2581 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | Dallas | Texas | 75390 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | Richmond | Virginia | 23298 | — |
| West Virginia University Pediactric Center | Charleston | West Virginia | 25302 | — |
| Research Site | Charleston | West Virginia | 72205 | — |
| Research Site | Huntington | West Virginia | 25701-3655 | — |
| Research Site | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00435227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2021 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00435227 live on ClinicalTrials.gov.